ABOUT CONCEIVIUM
OUR MISSION
From embryo to immunity — we strive to find solutions for every aspect of reproductive health.
Conceivium Biotech is using innovative genetic solutions to tackle reproductive health and assisted reproductive technology. We combine Next Generation Sequencing technology and qPCR to deliver the highest level of scientific excellence in every test we perform.
All of our tests are developed through extensive validation processes to ensure your results are as accurate as possible — because the decisions made from them matter.
01
Scientific Excellence
Next Generation Sequencing and qPCR technology, validated through rigorous protocols to deliver consistently accurate results.
02
Comprehensive Testing
From PGT to microbiome and immune analysis, our integrated panels cover every stage of the fertility journey under one roof.
03
Real-World Impact
Bridging clinical experience with scientific innovation to drive meaningful, measurable outcomes for the patients who depend on them.
OUR ORIGIN
Born from science. Driven by purpose.
Conceivium Biotech is led by Chief Scientific Officer Dr. Adam Pillon, PhD, who completed his doctorate at the University of Windsor in molecular and cell biology.
Through his dedication to driving Windsor’s biotech sector forward — and his deeply personal connection to assisted reproductive technology — Conceivium Biotech was born.
Today, Dr. Pillon brings his scientific knowledge and expertise to every testing protocol developed and validated at Conceivium, ensuring that every result we deliver is grounded in rigor, accuracy, and care.
MEET OUR FOUNDERS
The people behind the science.
Strategy meets science. Vision meets execution.
Dr. Adam Pillon, PhD
Chief Scientific Officer
Dr. Adam Pillon is the Chief Scientific Officer at Conceivium Biotech, where he leads the development and validation of the company’s testing platforms.
He holds a PhD in Molecular and Cell Biology from the University of Windsor and is deeply committed to advancing the local biotech sector. Combining his scientific expertise with a passion for innovation, Dr. Pillon plays a critical role in ensuring the accuracy, reliability, and clinical relevance of every test Conceivium delivers.
Marla Coffin
Chief Executive Officer
Marla is a seasoned entrepreneur and business leader with a track record of building and scaling companies across healthcare, real estate, and professional services. As CEO of Conceivium Biotech, she brings a strategic, operations-driven approach to advancing innovative testing solutions — translating scientific capability into real-world impact.
With deep experience in vertically integrated business models, Marla is known for identifying gaps in the market and building systems that improve efficiency, elevate quality, and drive growth. Her leadership is grounded in execution — bridging the gap between vision and results, and ensuring Conceivium delivers meaningful value to clinicians and the patients they serve.